Dalia Omran

1.2k total citations
73 papers, 779 citations indexed

About

Dalia Omran is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Dalia Omran has authored 73 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Epidemiology, 44 papers in Hepatology and 11 papers in Infectious Diseases. Recurrent topics in Dalia Omran's work include Liver Disease Diagnosis and Treatment (39 papers), Hepatitis C virus research (35 papers) and Hepatitis B Virus Studies (19 papers). Dalia Omran is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Hepatitis C virus research (35 papers) and Hepatitis B Virus Studies (19 papers). Dalia Omran collaborates with scholars based in Egypt, Saudi Arabia and United States. Dalia Omran's co-authors include Hend Ibrahim Shousha, Mohamed Nabil, Ashraf Omar Abdelaziz, Tamer Elbaz, Mohamed El‐Kassas, Eman M. Hassan, Ahmed Abdelmaksoud, Mahasen Mabrouk, Mohamed Alboraie and Eman Medhat and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The American Journal of Gastroenterology.

In The Last Decade

Dalia Omran

69 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dalia Omran Egypt 16 389 384 134 124 108 73 779
Asem Elfert Egypt 17 409 1.1× 379 1.0× 144 1.1× 110 0.9× 52 0.5× 61 852
Zhenzhen Zhang China 13 387 1.0× 301 0.8× 225 1.7× 87 0.7× 77 0.7× 45 761
Hend Ibrahim Shousha Egypt 13 381 1.0× 438 1.1× 83 0.6× 51 0.4× 70 0.6× 69 700
Etsuko Iio Japan 17 626 1.6× 584 1.5× 190 1.4× 144 1.2× 53 0.5× 52 842
Tamer Elbaz Egypt 19 725 1.9× 817 2.1× 127 0.9× 105 0.8× 98 0.9× 78 1.3k
Ayman Yosry Egypt 15 500 1.3× 467 1.2× 99 0.7× 44 0.4× 80 0.7× 60 782
Aisha Elsharkawy Egypt 17 668 1.7× 670 1.7× 72 0.5× 46 0.4× 57 0.5× 62 862
Lili Yuan China 16 150 0.4× 79 0.2× 151 1.1× 107 0.9× 46 0.4× 56 736
Ramou Njie Gambia 14 693 1.8× 632 1.6× 47 0.4× 69 0.6× 54 0.5× 26 870
Jiaji Jiang China 20 963 2.5× 895 2.3× 151 1.1× 83 0.7× 82 0.8× 56 1.2k

Countries citing papers authored by Dalia Omran

Since Specialization
Citations

This map shows the geographic impact of Dalia Omran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalia Omran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalia Omran more than expected).

Fields of papers citing papers by Dalia Omran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalia Omran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalia Omran. The network helps show where Dalia Omran may publish in the future.

Co-authorship network of co-authors of Dalia Omran

This figure shows the co-authorship network connecting the top 25 collaborators of Dalia Omran. A scholar is included among the top collaborators of Dalia Omran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalia Omran. Dalia Omran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
El‐Kassas, Mohamed, et al.. (2023). Prospective Comparison of Hepatocellular Carcinoma Behavior and Survival of Patients who Did or Did not Receive HCV Direct-Acting Antivirals. Asian Pacific Journal of Cancer Prevention. 24(2). 597–605. 2 indexed citations
4.
Salem, Marwa Rashad, et al.. (2022). COVID-19 Pandemic Preparedness in Egypt's Teaching Hospitals: A Needs Assessment Study. Frontiers in Public Health. 9. 748666–748666. 5 indexed citations
5.
Makhlouf, Nahed A., et al.. (2021). Colorectal cancer in Arab world: A systematic review. World Journal of Gastrointestinal Oncology. 13(11). 1791–1798. 23 indexed citations
6.
Shousha, Hend Ibrahim, Shimaa Afify, Noha Asem, et al.. (2021). Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study. World Journal of Gastroenterology. 27(40). 6951–6966. 8 indexed citations
7.
Afify, Shimaa, et al.. (2021). Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study. World Journal of Gastroenterology. 27(42). 7362–7375. 12 indexed citations
8.
Ibrahim, Marwa K., Mohamed Abdelrahman, Noha G. Bader El Din, et al.. (2021). The impact of genetic variations in sofosbuvir metabolizing enzymes and innate immunity mediators on treatment outcome in HCV-infected patients. Microbial Pathogenesis. 162. 105311–105311. 4 indexed citations
9.
Fouad, Hanan, et al.. (2020). Evaluation of Serum and Gene Expression of Galectin‐4, Interleukin‐27, and Complement‐7 in Hepatitis C Virus‐Infected Egyptian Patients. BioMed Research International. 2020(1). 8879758–8879758. 4 indexed citations
10.
El‐Kassas, Mohamed, Noha Asem, Ahmad Madkour, et al.. (2020). Clinical features and laboratory characteristics of patients hospitalized with COVID-19: single centre report from Egypt. The Journal of Infection in Developing Countries. 14(12). 1352–1360. 13 indexed citations
12.
El‐Kassas, Mohamed, Dalia Omran, Kadry Elsaeed, et al.. (2018). Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience. Journal of Interferon & Cytokine Research. 38(2). 81–85. 5 indexed citations
13.
14.
Omran, Dalia, et al.. (2017). Determinants of Infection Outcome in HCV-Genotype 4. Viral Immunology. 30(8). 560–567. 3 indexed citations
15.
Ibrahim, Marwa K., Hosny Salama, Reham M. Dawood, et al.. (2016). Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients. Journal of Interferon & Cytokine Research. 36(12). 698–705. 19 indexed citations
16.
Medhat, Eman, et al.. (2015). Serum Soluble CD14 in Egyptian Patients with Chronic Hepatitis C: Its Relationship to Disease Progression and Response to Treatment. Journal of Interferon & Cytokine Research. 35(7). 563–568. 8 indexed citations
17.
Omran, Dalia, et al.. (2015). Functional and morphological myocardial changes in hepatitis C virus patients with end-stage liver disease. Scandinavian Journal of Gastroenterology. 50(9). 1135–1143. 2 indexed citations
18.
El‐Bendary, Mahmoud, Gamal Esmat, Tarek Besheer, et al.. (2014). Epidemiological Aspects of Intrafamilial Spread of HCV Infection in Egyptian Population: A Pilot Study. Open Journal of Gastroenterology. 4(5). 228–236. 13 indexed citations
19.
Omran, Dalia, et al.. (2013). The effect of chronic khat chewing on liver enzyme levels: a Yemenian study. SHILAP Revista de lepidopterología. 25(1). 37–41. 3 indexed citations
20.
Omran, Dalia, et al.. (2011). Evaluation of serum LINE-1 hypomethylation as a prognostic marker for hepatocellular carcinoma. Arab Journal of Gastroenterology. 12(3). 139–142. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026